AzTrials
AzTrials

Critical IllnessNCT05385094

Consistency Between Measures of Renal Function in ICU Patients

An observational study of Critical Illness, run by Karolinska University Hospital at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aim to compare different measures of renal function (glomerular filtration rate) in ICU patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critical Illness
What is being tested?
S Creatinine concentration, Serum Cystatin C concentration and Urinary Creatinine Clearance
How many people
5,000 participants
Where
1 siteSweden
Study dates
1 Jan 2006to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: General ICU patients

Who may be able to join

  • ICU patients with at least one measurement of urinary creatinine clearance

Who cannot join

  • Renal replacement therapy initiated before the measurement of creatinine clerance

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska University Hospital Solna

    Stockholm, 17176

Other trials in Sweden

About this study

This study aim to compare different measures of renal function (glomerular filtration rate) in ICU patients.

Read the detailed description

The study uses a large dataset of prospectively collected data according to clinical routines.

Being tested
S Creatinine concentration, Serum Cystatin C concentration, Urinary Creatinine Clearance
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • S Creatinine concentrationDiagnostic test

  • Serum Cystatin C concentrationDiagnostic test

  • Urinary Creatinine ClearanceDiagnostic test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlations between estimates of renal function

    Measured: 7 days

  2. Correlations between changes in estimates of renal function

    Measured: 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2022
  2. Study start1 Jan 2006
  3. Primary completion31 Dec 2017
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
5,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05385094
Sponsor's protocol ID
EPN 2017/806-31 Renal Function
Status last verified
May 2022
First submitted
12 Dec 2021
Last updated
23 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: No plan.

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness, run by Karolinska University Hospital at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlations between estimates of renal function (time frame: 7 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in